Editing
Naive Mouse Antibody
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
[[File:Mouse synthetic library.png|RTENOTITLE]] <pre>germline gene 186.2 VH QVQLQQPGAELVKPGASVKMS CKASGYTFTSYNMHWVKQTPG RGLEWIGAIYPGNGYTSYNQKF KGKATLTADKSSSTAYMQLSSL TSEDSAVYYCARXXXX(X)(X)FD YWGQGTTVTVSS linker GGGGS GGGGS GGGG germline gene kv4-72 QIVLSQSPAILSASPGEKVTMTC RASSSVSYMHWFQQKPGSSPK PWIYATSNLASGVPVRFSGSGS GTSYSLTISRVEAEDAATYYCQQ XXXXPXTFGGGTKLEIKRTVAA BALB/c VH C C gtgcagctgcaggagtctggggctgagctggtgaagcctggggcctcagtgaagatgtcc V Q L Q E S G A E L V K P G A S V K M S V Q L Q Q P G A E L V K P G A S V K M S tgcaaggcttctggctacacatttaccagttacaatatgcactgggtaaagcagacacct C K A S G Y T F T S Y N M H W V K Q T P C K A S G Y T F T S Y N M H W V K Q T P G G T ggacagggcctggaatggattggaactatttatccaggaaatggtgatacttcctacaat G Q G L E W I G T I Y P G N G D T S Y N G R G L E W I G A I Y P G N G Y T S Y N cagaagttcaaaggcaaggccacattgactgcagacaaatcctccagcacagcctacatg Q K F K G K A T L T A D K S S S T A Y M Q K F K G K A T L T A D K S S S T A Y M cagctcagcagcctgacatctgaggactctgcggtctattactgtgcaagacggggtaac Q L S S L T S E D S A V Y Y C A R R G N Q L S S L T S E D S A V Y Y C A R ccctatgctatggactactggggtcaaggaacctcagtcaccgtctcctca P Y A M D Y W G Q G T S V T V S S F D Y W G Q G T T V T V S S Vk caaattgttctctcccagtctccagcaatcctgtctgcatctccaggggagaaggtcaca Q I V L S Q S P A I L S A S P G E K V T Q I V L S Q S P A I L S A S P G E K V T T atgacttgcagggccagctcaagtgtaagttacatgcactggtaccagcagaagccagga M T C R A S S S V S Y M H W Y Q Q K P G M T C R A S S S V S Y M H W F Q Q K P G T tcctcccccaaaccctggatttatgccacatccaacctggcttctggagtccctgctcgc S S P K P W I Y A T S N L A S G V P A R S S P K P W I Y A T S N L A S G V P V R C ttcagtggcagtgggtctgggacctcttattttctcacaatcagcagagtggaggctgaa F S G S G S G T S Y F L T I S R V E A E F S G S G S G T S Y S L T I S R V E A E gatgctgccacttattactgccagcagtggagtaataacccacgagcgctcacgttcggt D A A T Y Y C Q Q W S N N P R A L T F G D A A T Y Y C Q Q X X X X P X X X T F G gctgggaccaagctggagctgaaac A G T K L E L K G G T K L E I K R T V A A PHILOtop library construction primers a LMB3long 5'-CAGGAAACAGCTATGACCATGATTAC-3' b1 186_CDR304ba 5'-GTCCCTTGGCCCCAGTAGTCAAAMNNMNNMNNMNNTCTTGCACAATAATAGACCGCA-3' b2 186_CDR305ba 5'-GTCCCTTGGCCCCAGTAGTCAAAMNNMNNMNNMNNMNNTCTTGCACAATAATAGACCGCA-3' b3 186_CDR306ba 5'-GTCCCTTGGCCCCAGTAGTCAAAMNNMNNMNNMNNMNNMNNTCTTGCACAATAATAGACCGCA-3' c 186_CDR3fo 5'-TTTGACTACTGGGGCCAAGGGAC-3' d kv4-72_CDR3ba 5'-CGAGCTTGGTCCCCCCTCCGAACGTMNNCGGMNNMNNMNNMNNCTGCTGGCAGTAATAAGTGGC-3' e kv4-72_FR4NotIba 5'-TTTTCCTTTTGCGGCCGCTGCAGCCACAGTCCGTTTGATCTCGAGCTTGGTCCCCCCTCC-3' fdseqlong 5'-GACGTTAGTAAATGAATTTTCTGTATGAGG-3' PHILOtop affinity maturation library primers a LMB3long 5'-CAGGAAACAGCTATGACCATGATTAC-3' f CDR1VH 1aa ba 5'-GTGTCTGCTTTACCCAGTGCATMNNGTAGCTGGTGAAGGTGTAGC-3' g CDR2 VH 5aa fo 5'-CAGGGGTCTGGAATGGATCGGGNNMATTNNMCCTGGANNMGGTNNMACTNNMTACAATCAGAAGTTCAA GGGCAAG -3' h Ext FR1/2 ba 5'-CCGATCCATTCCAGACCCCTGCCAGGTGTCTGCTTTACCCAGTG -3' fdseqlong 5'-GACGTTAGTAAATGAATTTTCTGTATGAGG-3' (M=A/C, N=A/C/G/T) PHILOtop library construction primers a LMB3long 5'-CAGGAAACAGCTATGACCATGATTAC-3' reverse primers for heavy CDR3 b1 186_CDR304ba 5'-GTCCCTTGGCCCCAGTAGTCAAAMNNMNNMNNMNNTCTTGCACAATAATAGACCGCA-3' ( tgcggtctattattgtgcaagannmnnmnnmnnmtttgactactggggccaagggac A V Y Y C A R X X X X F D Y W G Q G ) b2 186_CDR305ba 5'-GTCCCTTGGCCCCAGTAGTCAAAMNNMNNMNNMNNMNNTCTTGCACAATAATAGACCGCA-3' b3 186_CDR306ba 5'-GTCCCTTGGCCCCAGTAGTCAAAMNNMNNMNNMNNMNNMNNTCTTGCACAATAATAGACCGCA-3' forward primer complement to reverse primers for heavy CDR3 c 186_CDR3fo 5'-TTTGACTACTGGGGCCAAGGGAC-3' F D Y W G Q G reverse primer for light chain CDR3 d kv4-72_CDR3ba 5'-CGAGCTTGGTCCCCCCTCCGAACGTMNNCGGMNNMNNMNNMNNCTGCTGGCAGTAATAAGTGGC-3' ( gccacttattactgccagcagnnmnnmnnmnnmccgnnmacgttcggaggggggaccaagctcg A T Y Y C Q Q X X X X P X T F G G G T K L ) reverse primer for light chain e kv4-72_FR4NotIba 5'-TTTTCCTTTTGCGGCCGCTGCAGCCACAGTCCGTTTGATCTCGAGCTTGGTCCCCCCTCC-3' ( Not1 ggaggggggaccaagctcgagatcaaacggactgtggctgca gcggccgc aaaaggaaaa G G G T K L E I K R T V A A A A A K G K ) fdseqlong 5'-GACGTTAGTAAATGAATTTTCTGTATGAGG-3' ======== PHILOtop affinity maturation library primers a LMB3long 5'-CAGGAAACAGCTATGACCATGATTAC-3' f CDR1VH 1aa ba 5'-GTGTCTGCTTTACCCAGTGCATMNNGTAGCTGGTGAAGGTGTAGC-3' g CDR2 VH 5aa fo 5'-CAGGGGTCTGGAATGGATCGGGNNMATTNNMCCTGGANNMGGTNNMACTNNMTACAATCAGAAGTTCAA GGGCAAG -3' h Ext FR1/2 ba 5'-CCGATCCATTCCAGACCCCTGCCAGGTGTCTGCTTTACCCAGTG -3' fdseqlong 5'-GACGTTAGTAAATGAATTTTCTGTATGAGG-3' (M=A/C, N=A/C/G/T) Synthetic genes (GenScript Corporation; NJ, USA) were used as templates for the PCR amplification of the variable heavy chain (VH) gene 186.2 (Bothwell, Paskind et al. 1981; Williams, Martinez et al. 2001; Chang and Mohan 2005) and for the amplification of the light variable chains (Vk) gene kv4-72 (Kirschbaum, Roschenthaler et al. 1999). The amplified fragments were used for the construction in the scFv format of the PHILOtop library. the linker Gly4SerGly4SerGly4 was introduced between the heavy and the light variable chain amplified genes (Table 3.1 and Figure 3.2). The resulting scFv segments were used for library construction as follows. Antibody residues are numbered according to (Chothia and Lesk 1987; Tomlinson, Cox et al. 1995) and are indicated in Figure 3.2. Sequence variability in the variable heavy chains component of the libraries was introduced by PCR using partially degenerated primers (Table 3.6 and Figure 3.2), in a process that generate random mutations at position 95-99 of the VH CDR3. The variable light chain components of the libraries were generated in a similar fashion, introducing random mutations at position 91, 92, 93, 94 and 96 in the Vk CDR3 (Table 3.6 and Figure 3.2). VH/Vk combinations were assembled in scFv format by PCR assembly, using gel purified VH and Vk segments as templates. The assembled VH/Vk fragments were doubly-digested with NcoI/NotI (New England Biolabs; MA, USA) and cloned (T4 DNA ligase, New England Biolabs; MA, USA) into NcoI/NotI-digested pHEN1 phagemid vector (Hoogenboom, Griffiths et al. 1991). </pre> [[Category:Antibodies]]
Summary:
Please note that all contributions to ELN may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
ELN:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
View history
More
Search
Navigation
Category:
Main page
To Do
Tasks
My ELN
Weekly Reports
Buffer Recipe
SOP
Protocols
Inventories
Projects
Products
Customers
Contacts
Suppliers
Vectors
Vector Map
Clones
Cloning
Sequencing
NGS
Protein Expression
Purchaseing
QC
293 Expression
CHO Expression
Sf9 Expression
Protein Purification
Stem Cells
Cytokines
Protein Kinases
GPCR
Cell Lines
Competent Cells
Viral Proteins
VLP
Baculovirus
AAV
Adenovirus
Lentivirus
Virus Titering
Antibodies
Transfection
ELISA
qPCR RT-PCR
ImmunoAssay
Multiplex BioAssa
Lateral_Flow
Conjugation
Compounds Synthesis
BioEngineering
GenomeEngineering
Services
Software
Ideas
Links
Knowledgebase
Employees
Company
Tools
What links here
Related changes
Page information
Navigation
Special pages